GENETICALLY MODIFIED NK-92 CELLS AND MONOCLONAL ANTIBODIES FOR THE TREATMENT OF CANCER
Publication
EP3273993A2
Kind: A2
Mar 25, 2026
Applicants
ImmunityBio, Inc.
Inventors
LEE, Tien, KLINGEMANN, Hans G., SIMON, Barry J., BOISSEL, Laurent, CAMPBELL, Kerry
IPC Classifications
A61K 40/15 20250101AFI20260122BHEP
A61K 40/42 20250101ALI20260122BHEP
A61K 35/17 20150101ALI20260122BHEP
A61K 38/16 20060101ALI20260122BHEP
A61K 39/395 20060101ALI20260122BHEP
A61P 35/00 20060101ALI20260122BHEP
A61P 35/02 20060101ALI20260122BHEP
A61P 35/04 20060101ALI20260122BHEP
A61P 43/00 20060101ALI20260122BHEP
C07K 16/28 20060101ALI20260122BHEP
C07K 16/32 20060101ALI20260122BHEP
C12N 5/0783 20100101ALI20260122BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR